TL/DR –
The Centers for Medicare and Medicaid Services (CMS) announced the termination of a subsidy program that has helped offset premiums for the past two years. The program, implemented in 2024 by the Biden administration in response to the effects of the 2022 Inflation Reduction Act, provided federal subsidies to private insurers to cap monthly premium hikes for prescription drug coverage. New York Governor Kathy Hochul and other state Democrats have criticized the move, stating that the end of the subsidy program will affect 1.3 million seniors in New York and could lead to increased costs for prescription drugs.
Trump Administration Ends Medicare Subsidy Program, Sparking Criticism
The recent decision by the Trump administration to terminate a two-year temporary subsidy program for Medicare has elicited strong reactions from New York officials. Centered in the harsh criticism is Governor Kathy Hochul, who referred to the move as “a new assault on seniors”.
The Centers for Medicare and Medicaid Services (CMS) made the announcement last week, stating that the implementation of the Part D Premium Stabilization Demonstration Program would cease by December 31, 2026. The program, originating from the Biden administration in 2024, aimed to offer federal subsidies to private insurers and moderate monthly premium increases for prescription drug coverage. Its creation was a response to the 2022 Inflation Reduction Act’s repercussions, intended to mitigate Medicare Part D prescription drug costs for patients.
Approximately 1.3 million seniors across New York are projected to be impacted by the termination of the program, according to Hochul. The governor voiced her concerns at a senior event, stating, “An assault on seniors by the Trump administration that is now taking away a subsidy for prescription drugs. So, your monthly premiums will go up. Thank you to the Republicans in Washington.”
Reactions from Political Figures and Organizations
Several Democrats from New York have also expressed their disapproval of the program’s ending. Sen. Kirsten Gillibrand referred to the decision as “a disaster for seniors,” sharing during a press conference Wednesday that countless seniors have shared their concerns about the potential fallout of the decision.
State Senator Gustavo Rivera, chair of the New York state Senate’s health committee, decried the decision, expressing concerns about the financial hardship it would impose on seniors already struggling with fixed incomes. Assemblymember Amy Paulin echoed similar sentiments, criticizing the move as one that increases drug costs for seniors when affordability is a crucial issue.
AARP Executive Vice President and Chief Advocacy and Engagement Officer, Nancy LeaMond, conveyed concern over the affordability of Part D coverage in light of this decision. However, she also noted that it’s too early to understand the full impact.
Countermeasures and Future Implications
In response to the potential premium increases, Gov. Hochul has expanded the Medicare Savings Program, which has reportedly increased enrollment by 20%, serving over a million people.
A CMS spokesperson defended their decision, suggesting that the Part D market is stabilizing after three turbulent years due to the Inflation Reduction Act redesign. They argued that the subsidies were always temporary to balance market instability and said data shows plan bids have stabilized. They further noted that 85% of beneficiaries will have access to a Part D plan with costs that are either lower or less than a $10 increase next year.
The decision to terminate the Medicare Part D subsidy program may have political repercussions. Political analysts speculate that Republicans who supported the healthcare cuts could face backlash in the November elections, given that seniors form a significant voting demographic nationwide.
—
Read More US Economic News